Open an account

Translational Development Acquisition

TDACU · NASDAQ

$11.33−$0.15 (−1.31%)TodayMarket closed ·
No price history for this range.

About TDACU

Translational Development Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York. The company went IPO on 2024-12-23. The firm is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target, and has not engaged in any substantive discussions, directly or indirectly, with any business combination target. The firm has neither engaged in any operations nor generated any revenues.

Employees
0
Headquarters
New York City, New York
Listed
Dec 23, 2024
Sector
N/A
Industry
N/A
Website
translational-development.com

TDACU key statistics

Market cap
210.08M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
5
Volume
195
Open price
$11.33
High today
$11.33
Low today
$11.33
52 Week high
$17.29
52 Week low
$10.71

Translational Development Acquisition (TDACU) at a glance

Translational Development Acquisition (TDACU) last traded at $11.33, with a market cap of 210.08M and a price-to-earnings ratio of 0.00.

Volume so far is 195 shares, above the average of 5 shares a day.

Over the past year Translational Development Acquisition has ranged from $10.71 to $17.29, and now sits 9% of the way up that range.

TDACU news

  • Press releasePRNewswire

    TDAC Announces ProLogium's Filing of F-4 As Continuing Momentum Towards Merger

  • Press releasePRNewswire

    TDAC Announces Very Successful Share Redemption Results in Connection with Extension Vote

  • Press releasePRNewswire

    Translational Development Acquisition Corp. Announces that the Separate Trading of its Class A Ordinary Shares and Warrants has Commenced

  • Press releasePRNewswire

    Translational Development Acquisition Corp. Announces Closing of $172.5 Million Initial Public Offering, Including Full Exercise of Underwriter's Over-Allotment Option

  • Press releasePRNewswire

    Translational Development Acquisition Corp. Announces the Pricing of $150,000,000 Initial Public Offering

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.